Clinical applications of fast liquid chromatography: A review on the analysis of cardiovascular drugs and their metabolites

I Baranowska, S Magiera, J Baranowski - Journal of Chromatography B, 2013 - Elsevier
One of the major challenges facing the medicine today is developing new therapies that
enhance human health. To help address these challenges the utilization of analytical …

Valsartan

F Ardiana, G Indrayanto - Profiles of drug substances, excipients and …, 2015 - Elsevier
Valsartan is an antihypertensive drug which selectively inhibits angiotensin receptor type II.
Generally, valsartan is available as film-coated tablets. This review summarizes thermal …

Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms

C Krishnaiah, AR Reddy, R Kumar… - Journal of pharmaceutical …, 2010 - Elsevier
A simple, precise, accurate stability-indicating gradient reverse phase ultra-performance
liquid chromatographic (RP-UPLC) method was developed for the quantitative …

[PDF][PDF] Bioavailability file: valsartan

M Saydam, S Takka - FABAD Journal of Pharmaceutical Sciences, 2007 - academia.edu
Valsartan is a new potent, highly selective and orally active antihypertensive drug belonging
to the family of angiotensin II type 1 receptor antagonists. Valsartan has much greater affinity …

Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tablets

RA Shaalan, TS Belal - Drug testing and analysis, 2010 - Wiley Online Library
Amlodipine, a dihydropyridine calcium channel blocker, and valsartan, an angiotensin II
receptor blocker, are co‐formulated in a single‐dose combination for the treatment of …

Nanosizing of valsartan by high pressure homogenization to produce dissolution enhanced nanosuspension: pharmacokinetics and pharmacodyanamic study

S Gora, G Mustafa, JK Sahni, J Ali, S Baboota - Drug Delivery, 2016 - Taylor & Francis
Purpose: The purpose of the present study was to formulate and evaluate nanosuspension
of Valsartan (VAL), a poorly water soluble and low bioavailable drug (solubility of 0.18 mg …

Simultaneous determination of valsartan and amlodipine besylate in human serum and pharmaceutical dosage forms by voltammetry

PE Erden, İH Taşdemir, C Kaçar, E Kılıç - International Journal of …, 2014 - Elsevier
Anodic behavior of binary mixture of amlodipine besylate (AMD) and valsartan (VAL) was
studied on glassy carbon electrode based on the irreversible oxidation signal of AMD at 0.95 …

Simultaneous determination of atorvastatin and valsartan in human plasma by solid-based disperser liquid–liquid microextraction followed by high-performance liquid …

MA Farajzadeh, P Khorram, A Pazhohan - Journal of Chromatography B, 2016 - Elsevier
A simple, sensitive, and efficient method has been developed for simultaneous estimation of
valsartan and atorvastatin in human plasma by combination of solid-based dispersive liquid …

Quantitative simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide in “Exforge HCT” tablets using high-performance liquid chromatography …

SJ Varghese, TK Ravi - Journal of Liquid Chromatography & …, 2011 - Taylor & Francis
Simple, accurate, precise, sensitive, and validated HPLC and HPTLC-densitometric
methods were developed for simultaneous determination of amlodipine (AML), valsartan …

Polyaniline immobilized on polycaprolactam nanofibers as a sorbent in electrochemically controlled solid-phase microextraction coupled with HPLC for the …

R Esfandiarnejad, H Sereshti, A Farahani - Analytical and bioanalytical …, 2019 - Springer
In this research, electrospun polycaprolactam nanofibers were collected on a fine stainless
steel mesh sheet without a binder, and a layer of conductive polyaniline was chemically …